These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 36728868)

  • 1. The fifth edition of the World Health Organization Classification and the International Consensus Classification of myeloid neoplasms: evolving guidelines in the molecular era with practical implications.
    Zheng G; Li P; Zhang X; Pan Z
    Curr Opin Hematol; 2023 Mar; 30(2):53-63. PubMed ID: 36728868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A practical approach on the classifications of myeloid neoplasms and acute leukemia: WHO and ICC.
    Xiao W; Nardi V; Stein E; Hasserjian RP
    J Hematol Oncol; 2024 Jul; 17(1):56. PubMed ID: 39075565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of the International Consensus Classification and World Health Organization 5th edition classification to a series of myeloid neoplasms.
    Chopra S; Bailey NG
    Am J Clin Pathol; 2023 Dec; 160(6):566-570. PubMed ID: 37587830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data.
    Arber DA; Orazi A; Hasserjian RP; Borowitz MJ; Calvo KR; Kvasnicka HM; Wang SA; Bagg A; Barbui T; Branford S; Bueso-Ramos CE; Cortes JE; Dal Cin P; DiNardo CD; Dombret H; Duncavage EJ; Ebert BL; Estey EH; Facchetti F; Foucar K; Gangat N; Gianelli U; Godley LA; Gökbuget N; Gotlib J; Hellström-Lindberg E; Hobbs GS; Hoffman R; Jabbour EJ; Kiladjian JJ; Larson RA; Le Beau MM; Loh ML; Löwenberg B; Macintyre E; Malcovati L; Mullighan CG; Niemeyer C; Odenike OM; Ogawa S; Orfao A; Papaemmanuil E; Passamonti F; Porkka K; Pui CH; Radich JP; Reiter A; Rozman M; Rudelius M; Savona MR; Schiffer CA; Schmitt-Graeff A; Shimamura A; Sierra J; Stock WA; Stone RM; Tallman MS; Thiele J; Tien HF; Tzankov A; Vannucchi AM; Vyas P; Wei AH; Weinberg OK; Wierzbowska A; Cazzola M; Döhner H; Tefferi A
    Blood; 2022 Sep; 140(11):1200-1228. PubMed ID: 35767897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the International Consensus and 5th WHO edition classifications of adult myelodysplastic syndromes and acute myeloid leukemia.
    Falini B; Martelli MP
    Am J Hematol; 2023 Mar; 98(3):481-492. PubMed ID: 36606297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of WHO-5 and ICC classifications in a series of myeloid neoplasms, considerations for hematopathologists and molecular pathologists.
    Moore ME; Williams E; Pelkey L; Courville EL
    Cancer Genet; 2024 Aug; 286-287():25-28. PubMed ID: 38964162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reporting bone marrow biopsies for myelodysplastic neoplasms and acute myeloid leukaemia incorporating WHO 5th edition and ICC 2022 classification systems: ALLG/RCPA joint committee consensus recommendations.
    Ng AP; Adams R; Tiong IS; Seymour L; Talaulikar D; Palfreyman E; Enjeti A; Tate C
    Pathology; 2024 Jun; 56(4):459-467. PubMed ID: 38580613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fifth Edition of the World Health Classification of Tumors of the Hematopoietic and Lymphoid Tissue: Myeloid Neoplasms.
    Loghavi S; Kanagal-Shamanna R; Khoury JD; Medeiros LJ; Naresh KN; Nejati R; Patnaik MM;
    Mod Pathol; 2024 Feb; 37(2):100397. PubMed ID: 38043791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid madness: assessing diagnostic inconsistency between the new WHO and ICC schemes for myelodysplastic/myeloproliferative neoplasms.
    Benton LG; Kallen ME; Jacobs JL; McCool IE; Ning Y; Duong VH; Koka R; Singh ZN
    J Clin Pathol; 2023 Dec; 77(1):68-72. PubMed ID: 37696594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the World Health Organization 2016 classification of myeloid neoplasms everyone should know.
    Hasserjian RP
    Curr Opin Hematol; 2018 Mar; 25(2):120-128. PubMed ID: 29256927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. International Consensus Classification of myeloid and lymphoid neoplasms: myeloproliferative neoplasms.
    Gianelli U; Thiele J; Orazi A; Gangat N; Vannucchi AM; Tefferi A; Kvasnicka HM
    Virchows Arch; 2023 Jan; 482(1):53-68. PubMed ID: 36580136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetics in the management of myeloproliferative neoplasms, mastocytosis and myelodysplastic/myeloproliferative neoplasms: Guidelines from the Group Francophone de Cytogénétique Hématologique (GFCH).
    Decamp M; Klein E; Godon C; Lestringant V; Roynard P; Theisen O; Jimenez-Pocquet M; Roche-Lestienne C; Bidet A; Veronese L
    Curr Res Transl Med; 2023; 71(4):103424. PubMed ID: 38011761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
    Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
    Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the diagnosis and classification of myeloid neoplasms--comments on the 2008 WHO classification.
    Yin CC; Medeiros LJ; Bueso-Ramos CE
    Int J Lab Hematol; 2010 Oct; 32(5):461-76. PubMed ID: 20626469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomics of myelodysplastic/myeloproliferative neoplasm.
    Patwardhan PP; Aarabi M; Aggarwal N
    Semin Diagn Pathol; 2023 May; 40(3):195-201. PubMed ID: 37105794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms.
    Thiele J; Kvasnicka HM; Orazi A; Gianelli U; Gangat N; Vannucchi AM; Barbui T; Arber DA; Tefferi A
    Am J Hematol; 2023 Jan; 98(1):166-179. PubMed ID: 36200127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The international consensus classification of eosinophilic disorders and systemic mastocytosis.
    Wang SA; Orazi A; Gotlib J; Reiter A; Tzankov A; Hasserjian RP; Arber DA; Tefferi A
    Am J Hematol; 2023 Aug; 98(8):1286-1306. PubMed ID: 37283522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants.
    Vardiman J; Hyjek E
    Hematology Am Soc Hematol Educ Program; 2011; 2011():250-6. PubMed ID: 22160042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic, Prognostic, and Predictive Utility of Recurrent Somatic Mutations in Myeloid Neoplasms.
    Patel U; Luthra R; Medeiros LJ; Patel KP
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S62-S74. PubMed ID: 28760304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The implications of revised WHO classification (2008) of chronic myeloid neoplasms.
    Găman M; Vlădăreanu AM; Radesi S
    Rom J Intern Med; 2011; 49(1):25-30. PubMed ID: 22026249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.